Related Experiment Video
Updated: Jul 18, 2026

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
Published on: April 16, 2019
Troglitazone-induced fulminant hepatitis: report of a case with autopsy findings
1Department of Pathology and Laboratory Medicine, UMDNJ-New Jersey Medical School, UH/E141, 185 South Orange Avenue, Newark, NJ 07103, USA.
Abstract:
Troglitazone is an insulin-sensitizing agent used to treat type 2 diabetes mellitus. Several cases have been reported of troglitazone-induced hepatic injury; some requiring transplantation, others resulting in death. We here present a case of troglitazone-induced fulminant hepatic necrosis that led to the death of the patient.
Related Concept Videos
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Hyperglycemia
Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology

